{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:54:17Z","timestamp":1791323657116,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008750","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jceh.2026.103603","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:54:47Z","timestamp":1782888887000},"page":"103603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Application Value of Ceramide and Sphingomyelin as Biomarkers for the Diagnosis of Drug-induced Liver Injury"],"prefix":"10.1016","volume":"16","author":[{"given":"Xuanlin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2026.103603_bib1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury \u2014 types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2026.103603_bib2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103603_bib3","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/j.apsb.2022.04.019","article-title":"Landscape of DILI-related adverse drug reaction in China mainland","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jceh.2026.103603_bib4","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and etiology of drug-induced liver injury in mainland China","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103603_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2174\/1389200219666180813144114","article-title":"Chinese herbal medicine hepatotoxicity: the evaluation and recognization based on large-scale evidence database","volume":"20","author":"Liu","year":"2019","journal-title":"Curr Drug Metabol"},{"key":"10.1016\/j.jceh.2026.103603_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jceh.2020.11.002","article-title":"The Indian network of drug-induced liver injury: etiology, clinical features, outcome and prognostic markers in 1288 patients","volume":"11","author":"Devarbhavi","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2026.103603_bib7","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103603_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2021.01.029","article-title":"Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry","volume":"75","author":"Stephens","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103603_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jceh.2026.103603_bib10","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1080\/17425255.2021.1999410","article-title":"Biomarkers of idiosyncratic drug-induced liver injury - a systematic review","volume":"17","author":"Atallah","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jceh.2026.103603_bib11","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s00204-021-03114-z","article-title":"Metabolomic analysis to discriminate drug-induced liver injury phenotypes","volume":"95","author":"Quint\u00e1s","year":"2021","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jceh.2026.103603_bib12","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/HEP.0000000000000458","article-title":"Future directions in acute liver failure","volume":"78","author":"Stravitz","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103603_bib13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41467-023-36858-6","article-title":"Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans","volume":"14","author":"Ravindra","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jceh.2026.103603_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12072-021-10144-3","article-title":"Drug-induced liver injury: Asia pacific association of study of liver consensus guidelines","volume":"15","author":"Devarbhavi","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2026.103603_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejim.2021.10.035","article-title":"Drug-induced liver injury: pathogenesis, epidemiology, clinical features, and practical management","volume":"97","author":"Bj\u00f6rnsson","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jceh.2026.103603_bib16","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr Biol"},{"key":"10.1016\/j.jceh.2026.103603_bib17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/metabo11120852","article-title":"Targeted metabolomics analysis of bile acids in patients with idiosyncratic drug-induced liver injury","volume":"11","author":"Xie","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.jceh.2026.103603_bib18","article-title":"Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jceh.2026.103603_bib19","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1021\/acs.jproteome.9b00047","article-title":"Metabolomics and cytokine analysis for identification of severe drug-induced liver injury","volume":"18","author":"Xie","year":"2019","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jceh.2026.103603_bib20","article-title":"Alteration of bile acids and omega-6 PUFAs are correlated with the progression and prognosis of drug-induced liver injury","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jceh.2026.103603_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00281-022-00910-2","article-title":"TNF in the liver: targeting a central player in inflammation","volume":"44","author":"Tiegs","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jceh.2026.103603_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0002-9610(00)00573-0","article-title":"Hepatic ischemia-reperfusion injury","volume":"181","author":"Serracino-Inglott","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.jceh.2026.103603_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1083780","article-title":"Hepatocytes: a key role in liver inflammation","volume":"13","author":"Gong","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jceh.2026.103603_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/bs.apha.2019.02.001","article-title":"Biomarkers of drug-induced liver injury","volume":"85","author":"McGill","year":"2019","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.jceh.2026.103603_bib25","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jceh.2026.103603_bib26","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.23696","article-title":"Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop","volume":"52","author":"Fontana","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2026.103603_bib27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"Arroyo","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103603_bib28","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2014update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jceh.2026.103603_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/toxsci\/kfu072","article-title":"Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNF\u03b1-mediated hepatotoxicity","volume":"140","author":"Fredriksson","year":"2014","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jceh.2026.103603_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.addr.2020.04.009","article-title":"Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods","volume":"159","author":"Van Kruining","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jceh.2026.103603_bib31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/cmi.2016.57","article-title":"CD24 aggravates acute liver injury in autoimmune hepatitis by promoting IFN-\u03b3 production by CD4+ T cells","volume":"15","author":"Zheng","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jceh.2026.103603_bib32","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: from physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103603_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015489","article-title":"Overexpression of Interleukin-8 promotes the progression of fatty liver to nonalcoholic steatohepatitis in mice","volume":"24","author":"Cho","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2026.103603_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00281-022-00910-2","article-title":"TNF in the liver: targeting a central player in inflammation","volume":"44","author":"Tiegs","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jceh.2026.103603_bib35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2023.02.033","article-title":"Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation","volume":"79","author":"Yahoo","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2026.103603_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","article-title":"Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction","volume":"81","author":"LeFort","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jceh.2026.103603_bib37","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2026.103603_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jceh.2026.103603_bib39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41586-024-07098-5","article-title":"IL-10 constrains sphingolipid metabolism to limit inflammation","volume":"627","author":"York","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jceh.2026.103603_bib40","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1053\/j.gastro.2020.06.031","article-title":"IRE1A stimulates hepatocyte-derived extracellular vesicles that promote inflammation in mice with steatohepatitis","volume":"159","author":"Dasgupta","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2026.103603_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153265","article-title":"Pulsatilla chinensis saponins cause liver injury through interfering ceramide\/sphingomyelin balance that promotes lipid metabolism dysregulation and apoptosis","volume":"76","author":"Su","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jceh.2026.103603_bib42","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cmet.2025.01.016","article-title":"Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism","volume":"37","author":"Jiang","year":"2025","journal-title":"Cell Metab"},{"key":"10.1016\/j.jceh.2026.103603_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5455\/medarh.2021.75.199-203","article-title":"Association between serum IL-6, IL-10, IL-12, and IL-23 levels and severity of liver cirrhosis","volume":"75","author":"Rey","year":"2021","journal-title":"Med Arch"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688326001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:45:46Z","timestamp":1791323146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688326001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0973688326001350"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103603","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Application Value of Ceramide and Sphingomyelin as Biomarkers for the Diagnosis of Drug-induced Liver Injury","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2026.103603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103603"}}